Scleroderma digital ulcers complicated by infection with fecal pathogens
Open Access
- 19 October 2011
- journal article
- other
- Published by Wiley in Arthritis Care & Research
- Vol. 64 (2), 295-297
- https://doi.org/10.1002/acr.20673
Abstract
Objective Digital ulcers represent one of the most frequent complications of systemic sclerosis (SSc; scleroderma); they are very painful, scarcely responsive to treatment, and often responsible for marked limitations on daily activities, including patient self‐care. Infectious complications may severely compromise the outcome of skin lesions in a significant percentage of patients. Numerous pathogens of different origin may be involved, including bacteria from patient endogenous flora. Here we evaluated the possible involvement of fecal pathogens in scleroderma digital ulcers. Methods Among a series of 82 SSc patients with digital ulcers, we retrospectively analyzed 42 subjects with clinical signs of local bacterial infection. All digital ulcers with suspected infection have been investigated by microbiologic examinations. Results Bacterial infection was confirmed in all 42 patients investigated; in particular, Staphylococcus aureus were the most frequently found (50%). Interestingly, 11 (26%) of 42 patients showed digital ulcers infected with intestinal bacteria; specifically, 7 patients were positive for Escherichia coli and 4 for Enterococcus faecalis. Diffuse cutaneous SSc patients were more numerous in this subgroup versus the other 31 patients (Fisher's P = 0.011). Conclusion A number of effective measures involving health care personnel and hospital environment are essential in the management of digital ulcers and prevention of infectious complications. In addition, the prevalence of fecal pathogens in one‐quarter of cases, never reported previously, suggests an important role of a patient's self‐care limitations, mainly during intercurrent home medications. Consequently, methodical education on hand hygiene of both patients and relatives, frequently involved in ulcer medications, is mandatory to avoid such deleterious complications.Keywords
This publication has 18 references indexed in Scilit:
- Differences in disability as measured by the Health Assessment Questionnaire between patients with and without digital ulcers in systemic sclerosis: a post hoc analysis of pooled data from two randomised controlled trials in digital ulcers using bosentan: Table 1Annals Of The Rheumatic Diseases, 2010
- Efficacy of tadalafil in secondary Raynaud’s phenomenon resistant to vasodilator therapy: a double-blind randomized cross-over trialRheumatology, 2010
- Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trialAnnals Of The Rheumatic Diseases, 2010
- Effect of sildenafil on digital ulcers in systemic sclerosis: analysis from a single centre pilot studyAnnals Of The Rheumatic Diseases, 2009
- Niedrig-Dosis-Kombinationstherapie schwerster digitaler Ulzerationen bei diffuser progressiver systemischer Sklerodermie mit dem Endothelin-1-Rezeptor-Antagonisten Bosentan und dem Phosphodiesterase-VInhibitor SildenafilJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2009
- Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosisArthritis & Rheumatism, 2007
- Digital ulcers: overt vascular disease in systemic sclerosisRheumatology, 2006
- Wound assessmentBMJ, 2006
- Wound healing and TIME; new concepts and scientific applicationsWound Repair and Regeneration, 2005
- A Causal Link Between Handwashing and Risk of Infection? Examination of the EvidenceInfection Control & Hospital Epidemiology, 1988